- Home
- NVX vs TIL Comparison
NVX vs TIL Comparison
Compare NVX & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- TIL
- Stock Information
- Founded
- NVX 2012
- TIL 2018
- Country
- NVX Australia
- TIL United States
- Employees
- NVX N/A
- TIL N/A
- Industry
- NVX Industrial Machinery/Components
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- NVX Miscellaneous
- TIL Health Care
- Exchange
- NVX Nasdaq
- TIL Nasdaq
- Market Cap
- NVX 210.3M
- TIL 177.1M
- IPO Year
- NVX N/A
- TIL 2021
- Fundamental
- Price
- NVX $1.23
- TIL $25.78
- Analyst Decision
- NVX
- TIL Buy
- Analyst Count
- NVX 0
- TIL 6
- Target Price
- NVX N/A
- TIL $120.50
- AVG Volume (30 Days)
- NVX 139.6K
- TIL 138.2K
- Earning Date
- NVX 01-01-0001
- TIL 11-12-2025
- Dividend Yield
- NVX N/A
- TIL N/A
- EPS Growth
- NVX N/A
- TIL N/A
- EPS
- NVX N/A
- TIL N/A
- Revenue
- NVX $5,931,433.00
- TIL N/A
- Revenue This Year
- NVX $135.22
- TIL N/A
- Revenue Next Year
- NVX $1,647.66
- TIL N/A
- P/E Ratio
- NVX N/A
- TIL N/A
- Revenue Growth
- NVX N/A
- TIL N/A
- 52 Week Low
- NVX $0.81
- TIL $10.80
- 52 Week High
- NVX $2.73
- TIL $76.13
- Technical
- Relative Strength Index (RSI)
- NVX 43.71
- TIL 47.60
- Support Level
- NVX $1.25
- TIL $22.67
- Resistance Level
- NVX $1.34
- TIL $33.83
- Average True Range (ATR)
- NVX 0.08
- TIL 2.51
- MACD
- NVX -0.02
- TIL -0.43
- Stochastic Oscillator
- NVX 9.37
- TIL 27.86
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.